B

Brainsway Ltd
NASDAQ:BWAY

Watchlist Manager
Brainsway Ltd
NASDAQ:BWAY
Watchlist
Price: 9.7 USD -10.19% Market Closed
Market Cap: 164.9m USD
Have any thoughts about
Brainsway Ltd?
Write Note

Intrinsic Value

The intrinsic value of one BWAY stock under the Base Case scenario is 11.32 USD. Compared to the current market price of 9.7 USD, Brainsway Ltd is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BWAY Intrinsic Value
11.32 USD
Undervaluation 14%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Brainsway Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BWAY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BWAY?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Brainsway Ltd

Provide an overview of the primary business activities
of Brainsway Ltd.

What unique competitive advantages
does Brainsway Ltd hold over its rivals?

What risks and challenges
does Brainsway Ltd face in the near future?

Summarize the latest earnings call
of Brainsway Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Brainsway Ltd.

Provide P/S
for Brainsway Ltd.

Provide P/E
for Brainsway Ltd.

Provide P/OCF
for Brainsway Ltd.

Provide P/FCFE
for Brainsway Ltd.

Provide P/B
for Brainsway Ltd.

Provide EV/S
for Brainsway Ltd.

Provide EV/GP
for Brainsway Ltd.

Provide EV/EBITDA
for Brainsway Ltd.

Provide EV/EBIT
for Brainsway Ltd.

Provide EV/OCF
for Brainsway Ltd.

Provide EV/FCFF
for Brainsway Ltd.

Provide EV/IC
for Brainsway Ltd.

Show me price targets
for Brainsway Ltd made by professional analysts.

What are the Revenue projections
for Brainsway Ltd?

How accurate were the past Revenue estimates
for Brainsway Ltd?

What are the Net Income projections
for Brainsway Ltd?

How accurate were the past Net Income estimates
for Brainsway Ltd?

What are the EPS projections
for Brainsway Ltd?

How accurate were the past EPS estimates
for Brainsway Ltd?

What are the EBIT projections
for Brainsway Ltd?

How accurate were the past EBIT estimates
for Brainsway Ltd?

Compare the revenue forecasts
for Brainsway Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Brainsway Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Brainsway Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Brainsway Ltd compared to its peers.

Compare the P/E ratios
of Brainsway Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Brainsway Ltd with its peers.

Analyze the financial leverage
of Brainsway Ltd compared to its main competitors.

Show all profitability ratios
for Brainsway Ltd.

Provide ROE
for Brainsway Ltd.

Provide ROA
for Brainsway Ltd.

Provide ROIC
for Brainsway Ltd.

Provide ROCE
for Brainsway Ltd.

Provide Gross Margin
for Brainsway Ltd.

Provide Operating Margin
for Brainsway Ltd.

Provide Net Margin
for Brainsway Ltd.

Provide FCF Margin
for Brainsway Ltd.

Show all solvency ratios
for Brainsway Ltd.

Provide D/E Ratio
for Brainsway Ltd.

Provide D/A Ratio
for Brainsway Ltd.

Provide Interest Coverage Ratio
for Brainsway Ltd.

Provide Altman Z-Score Ratio
for Brainsway Ltd.

Provide Quick Ratio
for Brainsway Ltd.

Provide Current Ratio
for Brainsway Ltd.

Provide Cash Ratio
for Brainsway Ltd.

What is the historical Revenue growth
over the last 5 years for Brainsway Ltd?

What is the historical Net Income growth
over the last 5 years for Brainsway Ltd?

What is the current Free Cash Flow
of Brainsway Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Brainsway Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Brainsway Ltd

Current Assets 55.5m
Cash & Short-Term Investments 81.5m
Receivables 3.8m
Other Current Assets -29.8m
Non-Current Assets 7.5m
Long-Term Investments 1.7m
PP&E 5.8m
Current Liabilities 9.8m
Accounts Payable 6.2m
Other Current Liabilities 3.5m
Non-Current Liabilities 11.6m
Other Non-Current Liabilities 11.6m
Efficiency

Earnings Waterfall
Brainsway Ltd

Revenue
31.8m USD
Cost of Revenue
-8.3m USD
Gross Profit
23.5m USD
Operating Expenses
-28.4m USD
Operating Income
-5m USD
Other Expenses
762k USD
Net Income
-4.2m USD

Free Cash Flow Analysis
Brainsway Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BWAY Profitability Score
Profitability Due Diligence

Brainsway Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional ROIC
ROIC is Increasing
39/100
Profitability
Score

Brainsway Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

BWAY Solvency Score
Solvency Due Diligence

Brainsway Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
66/100
Solvency
Score

Brainsway Ltd's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BWAY Price Targets Summary
Brainsway Ltd

There are no price targets for BWAY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BWAY?

Click here to dive deeper.

Dividends

Brainsway Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for BWAY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Brainsway Ltd

Country

Israel

Industry

Health Care

Market Cap

633.1m ILS

Dividend Yield

0%

Description

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Contact

JERUSALEM
19 Hartum Street, Bynet Building, 3Rd Fl, Har HaHotzvim
+97225813140.0
www.brainsway.com

IPO

2006-12-24

Employees

118

Officers

Chief Executive Officer
Mr. Hadar Levy
Founder & Director
Mr. Avner Hagai
Co-Founder, Member of Scientific Advisory Board & Director
Prof. Abraham Zangen
Founder & Chief Scientific Officer
Dr. Yiftach Roth Ph.D.
Chief Financial Officer
Mr. Ido Marom
Chief Technology Officer
Mr. Gilead Moiseyev
Show More
VP, General Counsel & Corporate Secretary
Mr. Menachem C. Klein Esq.
Vice President of Global Marketing
Mr. Ross Mitchell
Vice President of International Sales
Ms. Hillegonda Groen
Chief Medical Officer
Dr. Richard A. Bermudes M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BWAY stock?

The intrinsic value of one BWAY stock under the Base Case scenario is 11.32 USD.

Is BWAY stock undervalued or overvalued?

Compared to the current market price of 9.7 USD, Brainsway Ltd is Undervalued by 14%.

Back to Top